x |
Quarterly
report under Section 13 or 15(d) of the Securities Exchange Act of
1934
for the quarterly period ended March 31,
2007.
|
o |
Transition
report under Section 13 or 15(d) of the Securities Exchange Act of
1934
|
Delaware
(State
or other Jurisdiction of
Incorporation
or Organization)
|
77-0312442
(I.R.S.
Employer Number)
|
Yes o
|
No
x
|
Large
accelerated filer ¨
|
Accelerated filer ¨
|
Non-accelerated
filer x
|
Yes o
|
No
x
|
PART
I - FINANCIAL INFORMATION
|
|
Item
1. Condensed Consolidated Financial Statements
|
|
Condensed
Consolidated Balance Sheets at March 31, 2007 (unaudited) and December
31,
2006*
|
1
|
Unaudited
Condensed Consolidated Statements of Operations for the Three Months
ended
March 31, 2007 and 2006
|
2
|
Unaudited
Condensed Consolidated Statements of Stockholders’ Deficit for the three
months Ended March 31, 2007
|
3
|
Unaudited
Condensed Consolidated Statements of Cash Flows for the three months
Ended
March 31, 2007 and 2006
|
4
|
Notes
to Condensed Consolidated Financial Statements
|
5
|
Item
2. Management’s Discussion and Analysis of Financial Condition and Results
of Operations
|
13
|
Item
3. Quantitative and Qualitative Disclosures about Market
Risk
|
17
|
Item
4. Controls and Procedures
|
17
|
PART
II - OTHER INFORMATION
|
|
Item
1. Legal Proceedings
|
17
|
Item
1A. Risk Factors
|
17
|
Item
2. Unregistered Sales of Equity Securities and Use of
Proceeds
|
17
|
Item
3. Defaults upon Senior Securities
|
17
|
Item
4. Submission of Matters to a Vote of Security Holders
|
17
|
Item
5. Other Information
|
18
|
Item
6. Exhibits
|
18
|
Signatures
|
19
|
Certifications
|
20
|
* |
The
Condensed Consolidated Balance Sheet at December 31, 2006 has been
derived
from the audited consolidated financial statements filed as an exhibit
to
our Report on Form 10-K on June 6, 2007.
|
March
31, 2007
|
December
31, 2006
|
||||||
(Unaudited)
|
|||||||
ASSETS
|
|||||||
Current
assets:
|
|||||||
Cash
and cash equivalents
|
$
|
2,290
|
$
|
2,153
|
|||
Accounts
receivable, net of allowance for doubtful accounts of $132 and $121;
respectively
|
2,350
|
2,748
|
|||||
Prepaid
expenses and other current assets
|
527
|
327
|
|||||
Total
current assets
|
5,167
|
5,228
|
|||||
Property
and equipment, net
|
2,635
|
2,762
|
|||||
Other
assets
|
273
|
403
|
|||||
Total
assets
|
$
|
8,075
|
$
|
8,393
|
|||
LIABILITIES
AND STOCKHOLDERS’ DEFICIT
|
|||||||
Current
liabilities:
|
|||||||
Accounts
payable
|
$
|
2,259
|
$
|
1,957
|
|||
Accrued
expenses
|
2,205
|
1,906
|
|||||
Customer
deposits
|
329
|
102
|
|||||
Accrued
sales taxes and regulatory fees
|
4,210
|
4,216
|
|||||
Derivative
financial instruments
|
4,956
|
4,301
|
|||||
10%
Senior secured convertible notes, net of discount of $1,652 and $2,280,
respectively
|
5,119
|
4,326
|
|||||
Deferred
revenue
|
290
|
288
|
|||||
Total
current liabilities
|
19,368
|
17,096
|
|||||
Preferred
stock, $.0001 par value; 5,000 shares authorized and
redeemable;
0.120
Series B shares issued and outstanding, (stated value of $2,888;
liquidation
value of $3,820 and $3,735, respectively)
|
2,888
|
2,888
|
|||||
Commitments
and contingencies
|
|||||||
Stockholders’
deficit:
|
|||||||
Common
stock, $.0001 par value; 100,000 shares authorized; 46,750 and 46,390
shares issued
and
issuable; 46,710
and 46,350 shares outstanding, respectively
|
5
|
5
|
|||||
Additional
paid-in capital
|
161,327
|
161,267
|
|||||
Accumulated
deficit
|
(175,273
|
)
|
(172,623
|
)
|
|||
(13,941
|
)
|
(11,351
|
)
|
||||
Less:
Treasury stock, 40 shares at cost
|
(240
|
)
|
(240
|
)
|
|||
Total
stockholders’ deficit
|
(14,181
|
)
|
(11,591
|
)
|
|||
Total
liabilities and stockholders’ deficit
|
$
|
8,075
|
$
|
8,393
|
|
Three
Months Ended March 31,
|
||||||
2007
|
2006
|
||||||
Revenue
|
$
|
5,661
|
$
|
4,721
|
|||
Cost
of revenue
|
3,909
|
3,486
|
|||||
Gross
margin
|
1,752
|
1,235
|
|||||
Operating
expenses:
|
|||||||
Research
and development
|
161
|
271
|
|||||
Sales
and marketing
|
646
|
729
|
|||||
General
and administrative
|
1,951
|
4,653
|
|||||
Total
operating expense
|
2,758
|
5,653
|
|||||
Loss
from operations
|
(1,006
|
)
|
(4,418
|
)
|
|||
Other
expense (income):
|
|||||||
Interest
expense
|
915
|
1,638
|
|||||
Interest
income
|
(15
|
)
|
(4
|
)
|
|||
(Decrease)
increase in fair value of derivative financial instruments
|
614
|
(23
|
)
|
||||
Amortization
of deferred financing costs
|
130
|
—
|
|||||
Total
other expense, net
|
1,644
|
1,611
|
|||||
Net
loss
|
(2,650
|
)
|
(6,029
|
)
|
|||
Preferred
stock dividends
|
(85
|
)
|
(85
|
)
|
|||
Net
loss attributable to common stockholders
|
$
|
(2,735
|
)
|
$
|
(6,114
|
)
|
|
Net
loss attributable to common stockholders per share:
|
|||||||
Basic
and diluted
|
$
|
(0.06
|
)
|
$
|
(0.13
|
)
|
|
Weighted
average number of common shares:
|
|||||||
Basic
and diluted
|
46,540
|
46,046
|
Common
Stock
|
Paid
In
|
Accumulated
|
Treasury
Stock
|
|||||||||||||||||||
Shares
|
Amount
|
Capital
|
Deficit
|
Shares
|
Amount
|
Total
|
||||||||||||||||
Balance
at January 1, 2007
|
46,390
|
$
|
5
|
$
|
161,267
|
$
|
(172,623
|
)
|
40
|
$
|
(240
|
)
|
$
|
(11,591
|
)
|
|||||||
Net
loss
|
—
|
—
|
—
|
(2,650
|
)
|
—
|
—
|
(2,650
|
)
|
|||||||||||||
Comprehensive
loss
|
—
|
—
|
—
|
—
|
—
|
—
|
(2,650
|
)
|
||||||||||||||
Stock-based
compensation
|
—
|
—
|
83
|
—
|
—
|
—
|
83
|
|||||||||||||||
Issuance
of restricted stock
|
360
|
—
|
62
|
—
|
—
|
—
|
62
|
|||||||||||||||
Preferred
stock dividends
|
—
|
—
|
(85
|
)
|
—
|
—
|
—
|
(85
|
)
|
|||||||||||||
Balance
at March 31, 2007
|
46,750
|
$
|
5
|
$
|
161,327
|
$
|
(175,273
|
)
|
40
|
$
|
(240
|
)
|
$
|
(14,181
|
)
|
Three
Months Ended March 31,
|
|||||||
2007
|
2006
|
||||||
Cash
flows from Operating Activities:
|
|||||||
Net
loss
|
$
|
(2,650
|
)
|
$
|
(6,029
|
)
|
|
Adjustments
to reconcile net loss to net cash provided by (used in) operating
activities:
|
|||||||
Depreciation
and amortization
|
429
|
526
|
|||||
Other
expense (income) recognized for the increase (decrease) in the estimated
fair value of the derivative financial instruments
|
614
|
(23
|
)
|
||||
Amortization
of deferred financing costs
|
130
|
—
|
|||||
Accretion
of discount on 10% Notes
|
628
|
—
|
|||||
Beneficial
conversion feature for 10% Notes
|
41
|
1,586
|
|||||
Stock-based
compensation
|
145
|
297
|
|||||
Increase
(decrease) in cash attributable to changes in assets and
liabilities:
|
|||||||
Accounts
receivable
|
398
|
143
|
|||||
Prepaid
expenses and other current assets
|
(200
|
)
|
85
|
||||
Other
assets
|
—
|
6
|
|||||
Accounts
payable
|
302
|
822
|
|||||
Customer
deposits
|
227
|
(10
|
)
|
||||
Accrued
expenses, sales taxes and regulatory fees
|
373
|
1,623
|
|||||
Deferred
revenue
|
2
|
(58
|
)
|
||||
Net
cash provided by (cash used) in operating activities
|
439
|
(1,032
|
)
|
||||
Cash
flows from Investing Activities:
|
|||||||
Purchases
of property, equipment and leasehold improvements
|
(302
|
)
|
(121
|
)
|
|||
Net
cash used in investing activities
|
(302
|
)
|
(121
|
)
|
|||
Increase
(decrease) in cash and cash equivalents
|
137
|
(1,153
|
)
|
||||
Cash
and cash equivalents at beginning of period
|
2,153
|
2,023
|
|||||
Cash
and cash equivalents at end of period
|
$
|
2,290
|
$
|
870
|
|||
Supplement
disclosures of cash flow information:
|
|||||||
Cash
paid during the period for
|
|||||||
Interest
|
$
|
1
|
$
|
—
|
|||
Non-cash
investing and financing activities:
|
|||||||
Preferred
stock dividends
|
$
|
85
|
$
|
85
|
|||
Additional
10% Notes issued as payment for interest
|
165
|
—
|
|||||
Deferred
financing costs for 10% Notes incurred by issuance of placement agent
warrants
|
—
|
279
|
|||||
Proceeds
from March 2006 financing not yet received
|
—
|
5,179
|
Three
Months Ended March 31,
|
|||||||
2007
|
2006
|
||||||
Risk
free interest rate
|
4.7
|
%
|
4.3
|
%
|
|||
Expected
option lives
|
5
Years
|
5
Years
|
|||||
Expected
volatility
|
99.3
|
%
|
96.1
|
%
|
|||
Estimated
forfeiture rate
|
10
|
%
|
30
|
%
|
|||
Expected
dividend yields
|
None
|
None
|
|||||
Weighted
average grant date fair value of options
|
$
|
0.45
|
$
|
0.45
|
Outstanding
|
Exercisable
|
||||||||||||
|
Number
of Options
|
Weighted
Average
Exercise
Price
|
Number
of Options
|
Weighted
Average
Exercise
Price
|
|||||||||
Options
outstanding, January 1, 2007
|
5,100
|
$
|
2.26
|
3,664
|
$
|
2.86
|
|||||||
Granted
|
34
|
0.59
|
|||||||||||
Exercised
|
—
|
—
|
|||||||||||
Expired
|
(1,360
|
)
|
2.95
|
||||||||||
Forfeited
|
(148
|
)
|
1.61
|
||||||||||
Options
outstanding, March 31, 2007
|
3,626
|
$
|
2.02
|
2,230
|
$
|
2.84
|
|
Restricted
Shares
|
Weighted
Average
Exercise
Price
|
|||||
Unvested
restricted shares outstanding, January 1, 2007
|
317
|
$
|
0.71
|
||||
Granted
|
360
|
0.62
|
|||||
Vested
|
(97
|
)
|
1.35
|
||||
Forfeited
|
—
|
—
|
|||||
Unvested
restricted shares outstanding, March 31, 2007
|
580
|
$
|
0.53
|
Dec.
31, 2006
|
Activity
|
Mar.
31, 2007
|
||||||||
Principal
of 10% Notes:
|
||||||||||
March
2006 financing
|
$
|
5,665
|
$
|
—
|
$
|
5,665
|
||||
April
2006 financing
|
515
|
—
|
515
|
|||||||
Additional
10% Notes
|
426
|
165
|
591
|
|||||||
6,606
|
165
|
6,771
|
||||||||
Discount:
|
||||||||||
Derivative
financial instrument - Series A Warrants
|
(2,873
|
)
|
—
|
(2,873
|
)
|
|||||
Reduction
of exercise price and extension of expiration dates of
warrants
|
(766
|
)
|
—
|
(766
|
)
|
|||||
(3,639
|
)
|
—
|
(3,639
|
)
|
||||||
Accretion
of discount
|
1,359
|
628
|
1,987
|
|||||||
(2,280
|
)
|
628
|
(1,652
|
)
|
||||||
10%
Notes, net of discount
|
$
|
4,326
|
$
|
793
|
$
|
5,119
|
March
31, 2007
|
||||
Cash
financing costs:
|
||||
Placement
agent fees - Burnham Hill Partners
|
$
|
480
|
||
Other
financing costs
|
115
|
|||
595
|
||||
Placement
agent warrants - Burnham Hill Partners
|
296
|
|||
Financing
costs charged to additional paid in capital
|
(110
|
)
|
||
Total
financing costs
|
781
|
|||
Accumulated
amortization
|
(519
|
)
|
||
$
|
262
|
Dec.
31, 2006
|
Additions
|
Increase
(decrease) in Fair Value
|
Mar.
31, 2007
|
||||||||||
Derivative
financial instrument - February 2004 capital raise
|
$
|
1,236
|
$
|
—
|
$
|
(13
|
)
|
$
|
1,223
|
||||
Derivative
financial instrument - Beneficial conversion feature - 10%
notes
|
1,666
|
41
|
—
|
1,707
|
|||||||||
Derivative
financial instrument - Series A Warrants
|
1,399
|
—
|
627
|
2,026
|
|||||||||
$
|
4,301
|
$
|
41
|
$
|
614
|
$
|
4,956
|
2007
|
2006
|
||||||
Accretion
of discount on 10% Notes
|
$
|
628
|
$
|
—
|
|||
Interest
on 10% Notes
|
167
|
—
|
|||||
Beneficial
conversion feature - 10% Notes
|
41
|
1,586
|
|||||
Interest
expense for sales and use taxes and regulatory fees
|
78
|
52
|
|||||
Other
interest expense
|
1
|
—
|
|||||
$
|
915
|
$
|
1,638
|
(Unaudited)
Three
Months Ended
March
31,
|
|||||||
2007
|
2006
|
||||||
Revenue
|
100.0
|
%
|
100.0
|
%
|
|||
Cost
of revenue
|
69.1
|
73.8
|
|||||
Gross
margin
|
30.9
|
26.2
|
|||||
Operating
expenses:
|
|||||||
Research
and development
|
2.8
|
5.7
|
|||||
Sales
and marketing
|
11.4
|
15.4
|
|||||
General
and administrative
|
34.5
|
98.6
|
|||||
Total
operating expenses
|
48.7
|
119.7
|
|||||
Loss
from operations
|
(17.8
|
)
|
(93.5
|
)
|
|||
Other
expense (income):
|
|||||||
Interest
expense
|
16.2
|
34.6
|
|||||
Amortization
of deferred financing costs
|
2.3
|
──
|
|||||
Increase
(decrease) in fair value of derivative financial
instruments
|
10.8
|
(0.5
|
)
|
||||
Interest
income
|
(0.3
|
)
|
──
|
||||
Total
other expense, net
|
29.0
|
34.1
|
|||||
Net
loss
|
(46.8
|
)
|
(127.6
|
)
|
|||
Preferred
stock dividends
|
(1.5
|
)
|
(1.8
|
)
|
|||
Net
loss attributable to common stockholders
|
(48.3
|
)%
|
(129.4
|
)%
|
Contractual
Obligations:
|
Total
|
Less
Than 1 Year
|
1-3
Years
|
3-5
Years
|
More
than 5 Years
|
|||||||||||
10%
Notes
|
$
|
6,771
|
$
|
6,771
|
$
|
—
|
$
|
—
|
$
|
—
|
||||||
Derivative
liabilities
|
4,956
|
4,956
|
—
|
—
|
—
|
|||||||||||
Operating
lease obligations
|
213
|
207
|
6
|
—
|
—
|
|||||||||||
Commercial
commitments
|
6,080
|
3,343
|
2,737
|
—
|
—
|
|||||||||||
Total
|
$
|
18,020
|
$
|
15,277
|
$
|
2,743
|
$
|
—
|
$
|
—
|
31.1
|
Rule 13a-14(a)/15d-14(a) Certificate of Chief Executive Officer
|
|
31.2
|
Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer
|
|
32.1
|
Certificate of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
32.2
|
Certificate of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
GLOWPOINT,
INC.
Registrant
|
||
|
|
|
Date:
June 26, 2007
|
By: | /s/ Michael Brandofino |
Michael
Brandofino, Chief Executive Officer
(principal
executive officer)
|
||
|
|
|
Date:
June 26, 2007
|
By: | /s/ Edwin F. Heinen |
Edwin
F. Heinen, Chief Financial Officer
(principal
financial and accounting officer)
|
||